Trials Sponsors Conditions Drugs Pricing

Conditions

COVID19

Keywords

RT-PCR SARS-CoV-2Serology SARS-CoV-2Children

Outcome Measures

Primary Outcomes (1)

Proportion of asymptomatic children or children with mild respiratory symptoms
Proportion of asymptomatic children or children with mild respiratory symptoms (mildly-symptomatic children) with a positive SARS-Cov2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) on rhino pharyngeal swab or/and IgM/IgG positive serology in Paris area
At inclusion

Secondary Outcomes (4)

Cov2-SARS cases by age
At inclusion
Cov2-SARS cases by symptoms
At inclusion
Viral load
At inclusion
Presence of anti-SARS-CoV-2 antibodies (IgM and IgG) by the rapid serological test
At inclusion

Study Arms (1)

Children under 15 years of age in a community

Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc.

Diagnostic Test: RT-PCR SARS-Cov2Diagnostic Test: Sars-Cov2 serology

Interventions

RT-PCR SARS-Cov2Diagnostic test

nasopharyngeal swab will be taken for detection of SARS-CoV-2 by RT-PCR

Children under 15 years of age in a community

Sars-Cov2 serologyDiagnostic test

A microsample of blood will be taken for serology

Children under 15 years of age in a community

Eligibility Criteria

AgeUp to 15 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17)

Sampling MethodNon-Probability Sample

Study Population

Children under 15 years of age in a community (kindergarten, school, college, holiday centre, etc.).

You may qualify if:

Birth to 15 years old

Sponsors & Collaborators

Centre Hospitalier Intercommunal Creteil
Otherlead
Association Clinique Thérapeutique Infantile du val de Marne
Othercollaborator

MeSH Terms

Conditions

COVID-19

Interventions

COVID-19 Nucleic Acid Testing

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 2, 2020

First Posted

June 4, 2020

Study Start

November 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Stopped

Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO)

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (1)

Children under 15 years of age in a community

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (1)

Children under 15 years of age in a community

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record